Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Myasthenia Gravis × Mycophenolic Acid × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Lymphoma, Mantle-Cell 9 Lymphoma, Non-Hodgkin 8 Lymphoma, Large-Cell, Immunoblastic 8 Lymphoma, Large B-Cell, Diffuse 8 Lymphoma, Follicular 8 Leukemia, Myeloid, Acute 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Myelodysplastic Syndromes 7 Multiple Myeloma 7 Lymphoma 7 Congenital Abnormalities 7 Burkitt Lymphoma 7 Primary Myelofibrosis 6 Myeloproliferative Disorders 6 Lymphoma, T-Cell, Cutaneous 6 Lymphoma, B-Cell, Marginal Zone 6 Leukemia, Myeloid, Chronic-Phase 6 Leukemia, Myeloid, Accelerated Phase 6 Leukemia 6 Hodgkin Disease 6 Dendritic Cell Sarcoma, Interdigitating 6 Sezary Syndrome 5 Mycosis Fungoides 5 Leukemia, Myelomonocytic, Juvenile 5 Leukemia, Myelomonocytic, Chronic 5 Blast Crisis 5 Recurrence 4 Pdgfra-Associated Chronic Eosinophilic Leukemia 4 Leukemia, Neutrophilic, Chronic 4

Interventions

telitacicept 2 bu-zhong-yi-qi-tang 1 Walk Test 1 Sugammadex 1 Robotic Surgical Procedures 1 Rituximab 1 Psychodrama 1 Population Groups 1 Neostigmine 1 Mycophenolic Acid 1 Immunoglobulins 1 Cognitive Behavioral Therapy 1 Art Therapy 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00997412 2009-10-19

Myfortic

Qualitix Clinical Research Co., Ltd.

Phase NA Unknown

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡